Trevi Therapeutics, Inc. (TRVI)
11.05
-0.20
(-1.78%)
USD |
NASDAQ |
Feb 11, 16:00
11.04
-0.01
(-0.09%)
Pre-Market: 09:14
Trevi Therapeutics Total Assets (Quarterly) : 199.36M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CorMedix, Inc. | 750.86M |
| Arbutus Biopharma Corp. | 97.71M |
| Bristol Myers Squibb Co. | -- |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.568M |
| Shareholders Equity (Quarterly) | 189.79M |
| Debt to Equity Ratio | 0.0043 |
| Current Ratio | 21.93 |
| Net Debt Paydown Yield | 0.01% |